Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 2
2007 2
2008 3
2009 1
2010 1
2011 6
2012 1
2013 2
2014 3
2015 4
2016 3
2017 8
2018 9
2019 14
2020 12
2021 15
2022 13
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization.
Yerushalmi R, Pomerantz A, Lewin R, Paluch-Shimon S, Soussan-Gutman L, Baehner FL, Voet H, Bareket-Samish A, Kedar I, Goldberg Y, Peretz-Yablonski T, Kadouri L. Yerushalmi R, et al. Among authors: goldberg y. Breast Cancer Res Treat. 2024 Apr 3. doi: 10.1007/s10549-024-07271-4. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38568368
A POT1 Founder Variant Associated with Early Onset Recurrent Melanoma and Various Solid Malignancies.
Abu Shtaya A, Kedar I, Bazak L, Basel-Salmon L, Barhom SF, Naftali M, Eskin-Schwartz M, Birk OS, Polager-Modan S, Keidar N, Reznick Levi G, Levi Z, Yablonski-Peretz T, Mahamid A, Segol O, Matar R, Bareli Y, Azoulay N, Goldberg Y. Abu Shtaya A, et al. Among authors: goldberg y. Genes (Basel). 2024 Mar 13;15(3):355. doi: 10.3390/genes15030355. Genes (Basel). 2024. PMID: 38540414 Free PMC article. Review.
The Diagnostic Yield and Implications of Targeted Founder Pathogenic Variant Testing in an Israeli Cohort.
Abu Shtaya A, Kedar I, Mattar S, Mahamid A, Basel-Salmon L, Farage Barhom S, Naftaly Nathan S, Magal N, Azulay N, Levy Zalcberg M, Chen-Shtoyerman R, Segol O, Seri M, Reznick Levi G, Shkedi-Rafid S, Vinkler C, Netzer I, Hagari Bechar O, Chamma L, Liberman S, Goldberg Y. Abu Shtaya A, et al. Among authors: goldberg y. Cancers (Basel). 2023 Dec 24;16(1):94. doi: 10.3390/cancers16010094. Cancers (Basel). 2023. PMID: 38201524 Free PMC article.
The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
Laish I, Schechter M, Dancour A, Lieberman S, Levi Z, Goldberg Y, Kedar I, Hasnis E, Half E, Levi GR, Katz L, Vainer ED, Genzel D, Aharoni M, Chen-Shtoyerman R, Abu-Freha N, Raitses-Gurevich M, Golan T, Bernstein-Molho R, Ben Yehoyada M, Gluck N, Rosner G. Laish I, et al. Among authors: goldberg y. Cancer. 2024 Jan;130(2):256-266. doi: 10.1002/cncr.35052. Epub 2023 Oct 20. Cancer. 2024. PMID: 37861363
[INHERITED COLORECTAL CANCER - UPDATED REVIEW].
Abu Shtaya A, Goldberg Y. Abu Shtaya A, et al. Among authors: goldberg y. Harefuah. 2023 Jun;162(6):393-400. Harefuah. 2023. PMID: 37394444 Review. Hebrew.
105 results